Endostar
Endostar is a pharmaceutical drug with 45 clinical trials. Currently 1 active trials ongoing. Historical success rate of 90.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
34
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.9%
10 of 11 finished
9.1%
1 ended early
1
trials recruiting
45
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma
Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
Clinical Study of Endostatin in Improving Radiation Pneumonia and Fibrosis
Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma
Clinical Trials (45)
Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma
Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors
Clinical Study of Endostatin in Improving Radiation Pneumonia and Fibrosis
Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma
Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC
Endostar Combined With MPFC Adjuvant Treatment of Esophageal Cancer Clinical Trial
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma
Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma
PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy
A Trial of Endostar in Combination With Chemotherapy of DF and Sequential Intensity Modulated Radiation Therapy for Patients With Advanced Nasopharyngeal Carcinoma
SBRT With S1 Combined With Endostar in the Treatment of Lung Cancer
Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma
CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer
Endostar/PD-1 Inhibitors Combined With PP for Advanced NSCLC
Endostar Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy for Locoregional Nasopharyngeal Carcinoma
Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer
A Trial of Endostar in Patients With Carcinoma of the Head and Neck
Rh-Endostatin (Endostar®) Continuous Intravenous Infusion
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 45